Panacos Pharmaceuticals logo — Innovative solutions in the fight against HIV and other vira...

Panacos Pharmaceuticals

Innovative solutions in the fight against HIV and other viral diseases using advanced small-molecule oral drugs

Founded 1999 Post Ipo Debt Total: $58.30M Biotechnology, Health Care +1

General Information

Company Name Panacos Pharmaceuticals
Founded Year 1999
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post Ipo Debt
Social

Get notified when Panacos Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Panacos Pharmaceuticals

Panacos Pharmaceuticals is a biotechnology company founded in 1999 that focuses on developing innovative small-molecule oral drugs to combat HIV and other viral diseases. The company's research emphasizes unique targets in the virus life cycle, including maturation and fusion of the virus. With a product pipeline consisting of both second- and third-generation programs in HIV maturation inhibition, Panacos Pharmaceuticals is at the forefront of creating advanced solutions in the fight against HIV. Their latest investment of $20.00M in post-IPO debt was made on 28 June 2007 by Hercules Capital. Based in Watertown, Massachusetts, the company continues to make significant strides in the biotechnology, healthcare, and medical devices industries.

Taxonomy: Drug Discovery, Small-Molecule Drugs, Oral Drugs, Viral Diseases Treatment, HIV Treatment, Virus Life Cycle, Maturation Inhibition, Fusion Inhibition, Pharmaceutical Research, Innovative Drugs, HIV Research, Biotech Startups, Healthcare Innovation, Medical Technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1
Investor
28 Jun 2007
Post-IPO Equity •••••• 1
Investor
10 Dec 2004
Post-IPO Equity •••••• 8
Investor Investor Investor Investor Investor Investor
•••• ••••
18 May 2004

Panacos Pharmaceuticals Alternatives & Competitors

Panacos Pharmaceuticals vs

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a stron...

Post Ipo Equity
Biotechnology, Health Care
Panacos Pharmaceuticals vs

An innovation driven research company with the objective to develop drugs for treatments of viral in...

1 employees
Panacos Pharmaceuticals vs
OYAGEN INC.
OYAGEN INC. United States

OYAGEN is a biotechnology company formed on September 5, 2003, for the purpose of discovering, devel...

Grant
4 employees
Biotechnology, Health Care

FAQ About Panacos Pharmaceuticals

Innovative solutions in the fight against HIV and other viral diseases using advanced small-molecule oral drugs
Panacos Pharmaceuticals was founded in 1999.
Panacos Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Medical Devices.
Panacos Pharmaceuticals has completed 3 funding rounds, raising a total of $58.30M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Panacos Pharmaceuticals include Idenix Pharmaceuticals, Immune System Regulation AB, OYAGEN INC., Novira Therapeutics, Aids Programs South Saskatchewan. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Panacos Pharmaceuticals and Idenix Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Panacos Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy